Research

Experience the Benefits of Egg Membrane Collagen with Ovomet®

Our product, Ovomet®, uses natural collagen from eggshell membranes, supported by scientific and medical research.

Studies show that Ovomet® can quickly and effectively reduce joint pain and improve joint health, whether you're dealing with arthritis or looking to stay active and pain-free. It's a safe and natural way to take care of your joints. Learn more about how it works in the studies below.

1. Short-Term Effects of Ovomet® on Joint Pain in Osteoarthritis Patients

Recent research has shown that Ovomet®, a natural eggshell membrane supplement, can significantly reduce joint pain and dysfunction in people with osteoarthritis.

A 30-day double-blind, placebo-controlled study found that daily intake of at least 300 mg of Ovomet® led to noticeable improvements in joint pain as early as three days after starting the supplement. Participants who took Ovomet® experienced a 51.9% reduction in pain and a significant improvement in joint function compared to the placebo group.

Ovomet® offers a promising, fast-acting, and safe option for managing joint pain naturally.

To learn more about the study and its findings, read the full research here.

2. Effects of Ovomet® Supplementation on Crossfit Athletes: A Preliminary Study

A recent study explored the effects of Ovomet®, a natural eggshell membrane supplement, on joint biomechanics and pain perception in Crossfit athletes over a 50-day period.

The research focused on how Ovomet® impacts tendon stiffness, muscle power, and joint protection.

While the findings showed that Ovomet® helped maintain tendon stiffness and reduce joint pain perception compared to the placebo group, further research is needed to confirm its long-term benefits.

To read the full study, click here.

3. The Protective Role of Eggshell Membrane in Osteoarthritis Management

Osteoarthritis (OA) is a silent but widespread condition, affecting millions globally.

It is estimated that one in three women develops OA within the first five years of menopause, primarily due to estrogen decline, which accelerates cartilage degradation and joint inflammation.

Men, too, are significantly affected, particularly those with prior joint injuries, physically demanding occupations, or chronic inflammatory conditions.

As populations age, OA prevalence is rising, leading to increased disability and reliance on pain medications such as non-steroidal anti-inflammatory drugs (NSAIDs). However, long-term NSAID use poses risks, including gastrointestinal issues (ulcers, acid reflux), kidney damage, and cardiovascular complications (increased risk of heart attacks and strokes).

In contrast, collagen-rich eggshell membrane (ESM) offers a natural alternative without these risks, supporting joint health, inflammation reduction, and cartilage repair.

A recent study published in Nutrients examines the time-dependent effects of Ovomet®, a natural powdered ESM, on OA progression in a monosodium iodoacetate (MIA)-induced rodent model. The study highlights a two-phase protective mechanism of ESM:

  • Early-stage effects (within 7 days): ESM significantly reduced inflammation by suppressing key pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, along with inflammatory mediators like COX-2 and iNOS in knee joint cartilage.
  • Late-stage effects (28 days post-induction): ESM protected against cartilage degradation by reducing the expression of cartilage-degrading enzymes (MMP-3, MMP-13, ADAMTS-5) while promoting cartilage repair through increased production of collagen type II (COL2α1), aggrecan (ACAN), and cartilage extracellular matrix (ECM) components.

Given its dual-action benefits—early inflammation control and long-term cartilage protection—ESM may serve as a powerful functional ingredient for those at high risk, including postmenopausal women, aging adults, athletes, and individuals with chronic joint conditions.

As further research unfolds, ESM supplementation could provide a natural and effective approach to managing OA while minimizing dependence on conventional drug therapies.

Read the latest Full Research here.